ADVERTISEMENT
Search

 

Press Releases

 

12

Sep

2024

Study looks at market competition and vertical integration in PBM industry

New research published in JAMA finds a deep concentration of PBM services are evident across all three payer markets, especially Medicare Part D.

Comments (0)
Number of views (1232)
Article rating: No rating
Read more

Categories: APhA News

Tags: APhA News, PBMs

3

May

2022

CMS eliminates retroactive DIR fees

CMS has issued a final rule that put an end to PBM’s retroactive application of direct and indirect remuneration (DIR) fees, requiring that they be reflected in the negotiated price the patient pays at the pharmacy counter. The rule included all price concessions beginning on January 1, 2024.

Comments (0)
Number of views (14445)
Article rating: 3.9
Read more

Categories: APhA News

Tags: PBMs, DIR, CMS

18

Feb

2022

APhA expresses disappointment at failed Federal Trade Commission vote to study PBMs’ anticompetitive business practices

APhA urges the Federal Trade Commission (FTC) to reach a consensus to not only study, but fix the broken PBM marketplace

Author: Renee Kalu

WASHINGTON, D.C.—The American Pharmacists Association (APhA) issued the following statement in response to the FTC’s stalemate 2-2 vote today, which would have supported study of the competitive impact of contractual provisions, reimbursement adjustments, and other PBM practices affecting drug prices, including those practices that may disadvantage independent or specialty pharmacies.

Comments (0)
Number of views (3337)
Article rating: No rating
RSS
Advertisement
Advertisement
Advertisement
Advertisement
ADVERTISEMENT